Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Affimed (GB:0HL9)
LSE:0HL9
Holding GB:0HL9?
Track your performance easily
See the Price Targets and Ratings of:
0HL9 Analyst Ratings
Moderate Buy
2 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0HL9 Stock 12 Month Forecast
Average Price Target
$7.50
▲(101.83% Upside)
| Highest Price Target$10.00 | Average Price Target$7.50 | Lowest Price Target$5.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Truist Financial
Assigned
09/23/24
H.C. Wainwright
Reiterated
09/06/24
Stifel Nicolaus
Reiterated
09/05/24
Laidlaw
$15→$25
Buy
572.77%
Upside
Reiterated
06/12/24
Affimed Therapeutics (AFMD) PT Raised to $25 at LaidlawLaidlaw analyst Yale Jen raised the price target on Affimed Therapeutics (NASDAQ: AFMD) to $25.00 (from $15.00) while maintaining a Buy rating.
Leerink Partners
―
Buy
―
Reiterated
06/12/24
Analysts Offer Insights on Healthcare Companies: R1 RCM (NASDAQ: RCM), Affimed (NASDAQ: AFMD) and Nurix Therapeutics (NASDAQ: NRIX)
Wells Fargo
$25
Buy
572.77%
Upside
Reiterated
06/02/24
Analysts Are Bullish on Top Healthcare Stocks: Neurocrine (NBIX), Affimed (AFMD)
Jefferies
$70→$20
Buy
438.21%
Upside
Reiterated
04/04/24
Affimed Therapeutics (AFMD) PT Lowered to $20 at JefferiesJefferies analyst Maury Raycroft lowered the price target on Affimed Therapeutics (NASDAQ: AFMD) to $20.00 (from $70.00) while maintaining a Buy rating.
Best Analysts Covering Affimed
Which Analyst Should I Follow If I Want to Buy GB:0HL9 and Sell After:
1 Month
xxx
Success Rate
7/18 ratings generated profit
Average Return
-1.04%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 38.89% of your transactions generating a profit, with an average return of -1.04% per trade.
3 Months
xxx
Success Rate
4/18 ratings generated profit
Average Return
-13.94%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 22.22% of your transactions generating a profit, with an average return of -13.94% per trade.
1 Year
Success Rate
2/18 ratings generated profit
Average Return
-45.36%
reiterated a buy rating 5 months ago
Copying Daina Graybosch's trades and holding each position for 1 Year would result in 11.11% of your transactions generating a profit, with an average return of -45.36% per trade.
2 Years
xxx
Success Rate
2/18 ratings generated profit
Average Return
-58.69%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 11.11% of your transactions generating a profit, with an average return of -58.69% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0HL9 Analyst Recommendation Trends
Rating
Dec 23
Mar 24
Apr 24
Jun 24
Sep 24
Strong Buy
4
5
6
6
6
Buy
3
2
1
6
9
Hold
0
0
1
2
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
7
8
14
18
Each month's total comprises the sum of three months' worth of ratings.
0HL9 Financial Forecast
0HL9 Stock Forecast FAQ
What is GB:0HL9’s average 12-month price target, according to analysts?
Based on analyst ratings, Affimed’s 12-month average price target is $7.50.
What is GB:0HL9’s upside potential, based on the analysts’ average price target?
Affimed has 101.83% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Affimed a Buy, Sell or Hold?
Affimed has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
What is Affimed’s share price target?
The average share price target for Affimed is $7.50. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $10.00 ,and the lowest forecast is $5.00. The average share price target represents 101.83% Increase from the current price of $3.716.
The highest analyst share price target is $10.00 ,and the lowest forecast is $5.00. The average share price target represents 101.83% Increase from the current price of $3.716.
What do analysts say about Affimed?
Affimed’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of Affimed?
To buy shares of GB:0HL9, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.